Over 150 Total Lots Up For Auction at One Location - CA 05/31

Medtronic Paradigm Veo to Be Launched Globally But Not in U.S.

by Lynn Shapiro, Writer | September 09, 2009

Based on these results, the patient then programs the insulin pump to deliver an appropriate amount of insulin. Insulin combats high blood sugar, a key cause of heart disease and other long-term complications in type 1 diabetes.

However, if data transmitted from the sensor show the patient`s glucose levels have dropped below a defined threshold, the device's alarm alerts the patient. If these alarms are ignored, the insulin pump automatically suspends insulin delivery for up to two hours. This helps to protect against potentially dangerous hypoglycemic events.

"This latest technology is a significant breakthrough that will help people with
diabetes to control their condition. In order to reduce the long-term risk of diabetes-related complications, which can cause blindness, kidney failure and heart attacks, patients should manage their glucose levels to as near normal as possible. Unfortunately, aggressive glucose control can increase the risk of severe hypoglycemia, which can render a patient unconscious--and if recurrent--can have very serious consequences," says Prof. Dr. Tadej Battelino, head of the Department of Pediatric Endocrinology at Ljubljana`s University Children`s Hospital. "For the first time, a mechanical device can now warn the patient of this dangerous situation."

Source: Medtronic

Back to HCB News